These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22224448)

  • 1. Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: a role for dopaminergic therapy?
    Pignatti R; Brioschi A; Mauro A; Zamarian L; Wenter J; Semenza C
    Neurocase; 2012; 18(6):503-13. PubMed ID: 22224448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling.
    Garcia RF; Ordacgi L; Mendlowicz MV; de Freitas GR; Rosso AL; Nazar BP; Fontenelle LF
    Cogn Behav Neurol; 2007 Mar; 20(1):11-4. PubMed ID: 17356338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
    Hassan A; Bower JH; Kumar N; Matsumoto JY; Fealey RD; Josephs KA; Ahlskog JE
    Parkinsonism Relat Disord; 2011 May; 17(4):260-4. PubMed ID: 21310646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F; Schaefer F; Stuermer R; Boucsein W; Timmermann L; Barbe MT; Ebersbach G; Otto J; Kessler J; Kalbe E
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making in Parkinson's disease patients with and without pathological gambling.
    Rossi M; Gerschcovich ER; de Achaval D; Perez-Lloret S; Cerquetti D; Cammarota A; Inés Nouzeilles M; Fahrer R; Merello M; Leiguarda R
    Eur J Neurol; 2010 Jan; 17(1):97-102. PubMed ID: 19780806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iowa gambling task in Parkinson's disease.
    Poletti M; Cavedini P; Bonuccelli U
    J Clin Exp Neuropsychol; 2011 Apr; 33(4):395-409. PubMed ID: 21140314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decision-making and schizophrenia].
    Adida M; Maurel M; Kaladjian A; Fakra E; Lazerges P; Da Fonseca D; Belzeaux R; Cermolacce M; Azorin JM
    Encephale; 2011 Dec; 37 Suppl 2():S110-6. PubMed ID: 22212839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
    Bostwick JM; Hecksel KA; Stevens SR; Bower JH; Ahlskog JE
    Mayo Clin Proc; 2009 Apr; 84(4):310-6. PubMed ID: 19339647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathological gambling induced by dopamine agonists].
    Gahr M; Connemann BJ; Schönfeldt-Lecuona CJ
    Fortschr Neurol Psychiatr; 2011 Aug; 79(8):470-4. PubMed ID: 21809260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
    Kimber TE; Thompson PD; Kiley MA
    J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
    Bayard S; Langenier MC; Dauvilliers Y
    Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task.
    Kobayakawa M; Koyama S; Mimura M; Kawamura M
    Mov Disord; 2008 Mar; 23(4):547-52. PubMed ID: 18069681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of decision-making cognition in a case of frontotemporal lobar degeneration (FTLD) presenting with pathologic gambling and hoarding as the initial symptoms.
    Nakaaki S; Murata Y; Sato J; Shinagawa Y; Hongo J; Tatsumi H; Mimura M; Furukawa TA
    Cogn Behav Neurol; 2007 Jun; 20(2):121-5. PubMed ID: 17558256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who fails the Iowa Gambling Test (IGT)? Personality, neuropsychological, and near-infrared spectroscopy findings in healthy young controls.
    Suhr J; Hammers D
    Arch Clin Neuropsychol; 2010 Jun; 25(4):293-302. PubMed ID: 20237050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
    Grosset K; Needleman F; Macphee G; Grosset D
    Mov Disord; 2004 Nov; 19(11):1370-4. PubMed ID: 15389984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
    Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
    Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.